Detection and correlation of pre-operative, frozen section, and final pathology in high-risk endometrial cancer

Purpose: To evaluate sensitivity and specificity of pre-operative and frozen section pathologic evaluation (FSA) in predicting high-risk (HR) histology endometrial cancer. Materials and Methods: A retrospective analysis was performed on all patients diagnosed with endometrial cancer at a single institution. Medical records were abstracted for baseline characteristics, surgical reports for staging, and final histology was confirmed by a gynecologic pathologist. Results: 868 patients were identified. Of these, 118 had Grade 3 endometrioid, 36 clear cell carcinoma (CCC), 47 carcinosarcoma (CS), and 84 uterine papillary serous carcinoma (UPSC) histology. Endometrial biopsy (EMB) had an overall sensitivity of 90%, 77% for low grade, 78% for HR, with a specificity of 0%. For dilation and curettage (D&C), overall sensitivity was 85%, 69% for low grade, and 77% for HR. Specificity was 33%. Sensitivities for combined pre-operative testing for G3 endometrioid, CCC, CS, and UPSC were: 56%, 28%, 72%, and 60%, respectively. For frozen section analysis (FSA), overall sensitivity was 77%, and 67% for low and high grade. For G3 endometrioid, CCC, CS, and UPSC, sensitivities were 57%, 20%, 74%, 32%, respectively. Specificity was 95%. FSA identified an additional six patients (8%) with UPSC, CCC or CS that were pre-operatively low risk, providing an 8% improvement in sensitivity but decreased specificity. Conclusions: Pre-operative EMB and D&C are overall very sensitive for detecting endometrial cancer; however, sensitivity decreases with HR histology. Pre-op testing will miss 28% of HR diagnoses and FSA provides an opportunity to identify some patients with UPSC, CCC, and CS. If pre-operative results suggest HR cancer, the surgeon should proceed with comprehensive surgical staging without an FSA.

D&C; Pipelle; Frozen section; Endometrial cancer.

[1] Endometrial Cancer. NCI cancer statistics. Available at: http://www.cancer.gov/cancertopics/types/endometrial

[2] Dijkhuijen F.P., Mole B.W., Brolmann H.A., Heintz A.P.: “The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a Meta analysis”. Cancer, 2000, 89, 1765.

[3] Huang G.S., Gebb J.S., Einstein M.H., Shahabi S., Novetsky A.P., Goldberg G.L.: “Accuracy of preoparteive endometrial sampling for the detection of high-grade endometrial tumors”. Am. J. Obstet. Gynecol., 2007, 196, 243.

[4] Levine D.A., de Los Santos J., Fleming G.: Handbook for Principles and Practice of Gynecologic Oncology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2010.

[5] Celik C., Ozdemir S., Esen H., Balci O., Ylmaz O.: “Intraoperative assessments in the management of endometrial cancer”. Int. J. Gynecol. Cancer, 2010, 20, 358.

[6] Kumar S., Medeiros F., Dowdy S.C., Keeney G.L., Bakkum-Gamez J.N., Podratz K.C., et al.: “A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer”. Gynecol. Oncol., 2012, 127, 525.

[7] Quilivan J., Petersen R.W., Nicklin J.L.: “Accuracy of frozen section for the operative management of endometrial Cancer”. BJOG, 2001, 108, 798.

[8] Frumovitz M., Slomovitz B.M., Singh D.K., Broaddus R.R., Abrams J., Sun C.C., et al.: “Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer”. J. Am. Coll. Surg., 2004, 199, 388.

[9] Case A.S., Rocconi R.P., Straughn J.M. Jr., Conner M., Novak L., Wang W., Huh WK.: “A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer”. Obstet. Gynecol., 2006, 108, 1375.

[10] Turan T., Oguz E., Unlubilgin E., Tulunay G., Boran N., Demir O.F., Kose M.F.: “Accuracy of frozen-section examination for myometrial invasion and grade in endometrial cancer”. Eur. J. Obstet. Gynecol., 2013, 167, 90.

[11] Fanning J., Tsukada Y., Piver M.S.: “Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma”. Gynecol. Oncol., 1990, 37, 47.

[12] Kucera E., Kaine C., Reinthaller A., Sliutz G., Leodolter S., Kucera H., Breitenecker G.: “Accuracy of intraoperative frozen-section diagnosis in stage 1 endometrial adenocarcinoma”. Gynecol. Obstet. Invest., 2000, 49, 62.

[13] Noumoff J.S., Menzin A., Mikuta J., Lusk E.J., Morgan M., LiVolsi VA.: “The ability to evaluate prognostic variables on frozen section in hysterectomies performed for endometrial carcinoma”. Gynecol. Oncol., 1991, 42, 202.

[14] Soliman P.T., Frumovitz M., Spannuth W., Greer M.J., Sharma S., Schmeler K.M., et al.: “Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists”. Gynecol. Oncol., 2010, 119, 291.

[15] Zaino R.J., Kauderer J., Trimble C.L., Silverberg S.G., Curtin J.P., Lim P.C., Gallup D.G.: “Reproducibility of the diagnosis of atypical endometrial hyperplasia”. Cancer, 2006, 106, 804.